Construction of a predictive model for assessing the risk of noncardioembolic ischemic stroke

DOI: https://doi.org/10.29296/25877305-2020-11-16
Download full text PDF
Issue: 
11
Year: 
2020

V. Shishkova(1, 2), Candidate of Medical Sciences; Professor T. Adasheva(2), MD; Professor L.
Stakhovskaya(3), MD (1)National Medical Research Center for Therapy and Preventive Therapy, Ministry of
Health of Russia, Moscow (2)A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of
Health of Russia, Moscow (3)N.I. Pirogov Russian National Research Medical University, Moscow

Objective. To develop a predictive model to assess the risk of a first noncardioembolic ischemic stroke (IS). Subjects and methods. A case-control study enrolled 412 participants aged 45 to 80 years, including 206 patients who had experienced a first noncardioembolic IS and 206 healthy volunteers who had not and were matched for gender and age to those in the study group. In all the participants of the investigation, their blood was taken from the cubital vein in the morning on an empty stomach after 12-hour fasting, and was estimated using the concentrations of markers, such as glucose, insulin, total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides, apolipoproteins B and A1, homocysteine, C-reactive protein, interleukins 1, 4, 6, 8, and 10, vascular endothelial growth factor A, tumor necrosis factor-α, adiponectin, uric acid, N-terminal propeptide of natriuretic hormone, creatinine, and cystatin C. All the participants underwent genotyping of 25 single nucleotide polymorphisms (SNPs): APOE (rs7412, rs429358, rs5174), APOA5 (rs34282181, rs619054), APOC4 (rs1132899), APON (rs4581), LPL (rs199675233), LPL (rs199675233), LP(a) (rs41267817), APOB (rs1042031, rs676210), АРОD (rs7659), ANGPT4 (rs1044250), TNFа (rs1800620), VEGFA (rs62401172), IL8 (rs1803205), IL6 (rs56383910), MTHFR (rs1801131, rs1801133), ADIPOQ-AS1 (rs17366743, rs185847354), ADIPOR2 (rs12342), GRM1 (rs1047005), GRM3 (rs2228595), and BDNF (rs6265). Analysis of allele recognition by a polymerase chain reaction assay using the ready-made TaqMan probes with Assey ID identification number (Applied Biosystems, USA). Results. The resulting model included the following independent variables: type 2 diabetes mellitus (DM2), adiponectin, ApoA1, IL6, ADIPOQ (rs17366743). The area under the curve (AUC) (95% confidence interval) was 0.947 (0.918; 0.976), the cut-off threshold was 0.565, while the sensitivity of the model was 87.1%, the specificity was 90.3%; the percentage of correct reclassification was 88.7%. Conclusion. The resulting predictive model includes clinical, biochemical, and molecular genetic parameters and is characterized by the high sensitivity, specificity, and accuracy of reclassification.
Keywords: 
neurology
noncardioembolic ischemic stroke
predictive model

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Stahovskaja L.V., Kotov S.V., Isakova E.V. Insul't: rukovodstvo dlja vrachej. M: OOO «Meditsinskoe informatsionnoe agentstvo», 2013; 400 s. [Stakhovskaya L.V., Kotov S.V., Isakova E.V. Insul’t: rukovodstvo dlya vrachei. M: OOO «Meditsinskoe informatsionnoe agentstvo», 2013; 400 s. (in Russ.)].
  2. Stahovskaja L.V., Klochihina O.A., Bogatyreva M.D. i dr. Epidemiologija insul'ta v Rossii po rezul'tatam territorial'no-populjatsionnogo registra (2009–2010). Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013; 113 (5): 4–10 [Stakhovskaia L.V., Klochikhina O.A., Bogatyreva M.D. et al. Epidemiology of stroke in the Russian Federation: results of territory’s population registry (2009–2010). S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2013; 113 (5): 4–10 (in Russ.)]
  3. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14 (3): 173–94. DOI: 10.2337/diacare.14.3.173
  4. Shishkova V.N. Mehanizmy razvitija serdechno-sosudistyh zabolevanij i saharnogo diabeta tipa 2: rol' insulinorezistentnosti, giperinsulinemii i gipoadiponektinemii. Voprosy korrektsii. Sistemnye gipertenzii. 2014; 2: 48–53 [Shishkova VN. The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management. Systemic Hypertension. 2014; 11 (2): 48–53 (in Russ.)].
  5. Hobbs F.D., Davis R.C., Roalfe A.K. et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 2002; 232 (7352): 1498–500. DOI: 10.1136/bmj.324.7352.1498
  6. Wang Y., Li W., Yang J. et al. Association between cystatin C and the risk of ischemic stroke: a systematic review and meta-analysis. J Mol Neurosci. 2019; 69 (3): 444–9. DOI: 10.1007/s12031-019-01373-1
  7. Jeon S.B., Kang D.W., Kim J.S. et al. Homocysteine, small-vessel disease, and atherosclerosis: an MRI study of 825 stroke patients. Neurology. 2014; 83 (8): 695–701. DOI: 10.1212/WNL.0000000000000720
  8. Zhao X., Wang H., Sun G. et al. Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci. 2015; 35 (32): 11281–91. DOI: 10.1523/JNEUROSCI.1685-15.2015
  9. Bang O.Y., Savel J.L., Ovbiagele V. et al. Adiponectin levels in patients with intracranial atherosclerosis. Neurology. 2007; 68 (22): 1931–7. DOI: 10.1212/01.wnl.0000263186.20988.9f
  10. Dong H., Chen W., Wang X. et al. Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study. Metab Brain Dis. 2015; 30 (6): 1319–30. DOI: 10.1007/s11011-015-9732-7
  11. Doll N.D., Barr T.L., Simpkin J.W. Cytokines: Their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis. 2014; 5 (5): 294–306. DOI: 10.14336/AD.2014.0500294